BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29332117)

  • 1. Pseudocholinesterase levels in patients under electroconvulsive therapy.
    Küçükosman G; Pişkin Ö; Hancı V; Okyay RD; Ayoğlu H; Yurtlu BS; Akın M; Turan IÖ
    Saudi Med J; 2018 Jan; 39(1):103-106. PubMed ID: 29332117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of electroconvulsive therapy on blood glucose, creatinine levels, and lipid profile and its association with the type of psychiatric disorders.
    Ghanizadeh A; Issaee M; Sigaroody MO; Kaviani K
    Neurochem Int; 2012 Dec; 61(7):1007-10. PubMed ID: 22828190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum pseudocholinesterase and very-low-density lipoprotein metabolism.
    Kutty KM; Payne RH
    J Clin Lab Anal; 1994; 8(4):247-50. PubMed ID: 7931819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudocholinesterase deficiency and electroconvulsive therapy.
    Williams J; Rosenquist P; Arias L; McCall WV
    J ECT; 2007 Sep; 23(3):198-200. PubMed ID: 17805000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudocholinesterase activity in cerebrospinal fluid as a biomarker of solid central nervous system tumors in children.
    Mikecin L; Krizmaric M; Stepan Giljevic J; Gjurasin M; Kern J; Lenicek Krleza J; Popovic L
    Croat Med J; 2013 Oct; 54(5):429-35. PubMed ID: 24170721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive Therapy Considerations for Transgendered Patients.
    Tran BK; O'Donnell SE; Balla A; Adams DC; Grondin LS; Tsai MH
    J ECT; 2017 Jun; 33(2):e14-e16. PubMed ID: 28009618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirror-Image Study of Maintenance Electroconvulsive Therapy.
    Mota J; Rodrigues-Silva N
    J ECT; 2016 Jun; 32(2):119-21. PubMed ID: 26704129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute electroconvulsive therapy followed by maintenance electroconvulsive therapy decreases hospital re-admission rates of older patients with severe mental illness.
    Shelef A; Mazeh D; Berger U; Baruch Y; Barak Y
    J ECT; 2015 Jun; 31(2):125-8. PubMed ID: 25373561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroconvulsive therapy in Norway: rates of use, clinical characteristics, diagnoses, and attitude.
    Schweder LJ; Lydersen S; Wahlund B; Bergsholm P; Linaker OM
    J ECT; 2011 Dec; 27(4):292-5. PubMed ID: 21983754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of electroconvulsive therapy in the treatment of psychiatric illness at Umzimkulu Hospital in Transkei. A retrospective study.
    Mugisha RX; Ovuga EB
    S Afr Med J; 1991 Apr; 79(7):391-3. PubMed ID: 2014464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological analysis of electroconvulsive therapy in Victoria, Australia.
    Wood DA; Burgess PM
    Aust N Z J Psychiatry; 2003 Jun; 37(3):307-11. PubMed ID: 12780469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroconvulsive therapy in adolescents: a retrospective study from north India.
    Grover S; Malhotra S; Varma S; Chakrabarti S; Avasthi A; Mattoo SK
    J ECT; 2013 Jun; 29(2):122-6. PubMed ID: 23296394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 10-year descriptive study of electroconvulsive therapy at the Neuropsychiatric Hospital, Aro, Abeokuta.
    Somoye EB; Onifade PO; Oluwaranti AO; Adeniji AA
    J ECT; 2014 Dec; 30(4):315-9. PubMed ID: 24625716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudocholinesterase Enzyme Deficiency in Adıyaman City Area.
    Abdullayev R; Küçükebe ÖB; Kaya R; Çelik B; Kuşderci H; Duran M; Uludağ Ö; Öterkuş M; Buyrukcan A; Sabuncu Ü; Arpacı A
    Turk J Anaesthesiol Reanim; 2015 Dec; 43(6):381-6. PubMed ID: 27366534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in electroconvulsive therapy: a retrospective chart review.
    Bloch Y; Ratzoni G; Sobol D; Mendlovic S; Gal G; Levkovitz Y
    J Affect Disord; 2005 Jan; 84(1):99-102. PubMed ID: 15620391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electroconvulsive therapy in Massachusetts.
    Mills MJ; Pearsall DT; Yesavage JA; Salzman C
    Am J Psychiatry; 1984 Apr; 141(4):534-8. PubMed ID: 6703132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent Electroconvulsive Therapy and Bupropion Treatment.
    Takala CR; Leung JG; Murphy LL; Geske JR; Palmer BA
    J ECT; 2017 Sep; 33(3):185-189. PubMed ID: 28570500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not Available].
    Mechri A; Zaafrane H; Khalifa MH; Toumi S; Zaafrane F; Gaha L
    Pan Afr Med J; 2018; 29():6. PubMed ID: 29632628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment serum pseudocholinesterase level as a novel prognostic biomarker for upper tract urothelial carcinoma.
    Zhang B; Shen C; Jin J; Song Y; Zhao Z; Zhang X; Wang G; Fan Y; Mi Y; Hu S; Cui Y; Zhou L; He Z; Yu W; Han W
    Int Urol Nephrol; 2016 Dec; 48(12):1993-1999. PubMed ID: 27554671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.